Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Company research history

ica SpringWorks Therapeutics, Inc. - common stock (SWTX)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

7 disclosures

3 insiders

0 cluster signals

0.0% avg. 30d outcome

Company facts

Ticker / ISIN: SWTX / Not available
Exchange: Not available
Country: US
Sector: Not available

Related insiders

Christopher L. Jacobs

Representative, 1 disclosure

Gilbert Cisneros

Representative, 2 disclosures

Josh Gottheimer

Representative, 4 disclosures

Disclosure history

Josh Gottheimer, Representative

sell disclosed on 11 Aug 2025 via House STOCK Act disclosures

View signal Open source

Transaction value: 1.001 US$
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Gilbert Cisneros, Representative

sell disclosed on 10 Jul 2025 via House STOCK Act disclosures

View signal Open source

Transaction value: Not available
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Gilbert Cisneros, Representative

buy disclosed on 11 Feb 2025 via House STOCK Act disclosures

View signal Open source

Transaction value: 1.001 US$
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Josh Gottheimer, Representative

buy disclosed on 15 Aug 2024 via House STOCK Act disclosures

View signal Open source

Transaction value: 1.001 US$
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Josh Gottheimer, Representative

sell disclosed on 9 Jul 2024 via House STOCK Act disclosures

View signal Open source

Transaction value: 1.001 US$
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Josh Gottheimer, Representative

buy disclosed on 8 Jun 2024 via House STOCK Act disclosures

View signal Open source

Transaction value: 1.001 US$
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Christopher L. Jacobs, Representative

buy disclosed on 20 Jan 2023 via House STOCK Act disclosures

View signal Open source

Transaction value: 1.001 US$
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%